Calreticulin Exon 9 Mutation

Genetic test for myeloproliferative neoplasms, often used with other molecular tests.

Test description

Calreticulin (CALR) exon 9 mutations are seen in a number of myeloproliferative neoplasms. Consider CALR mutations in conjunction with or following other molecular tests for these disorders.

Test information

Test name

CALR (Calreticulin)

Clinical indication

In the diagnostic workup of myeloproliferative neoplasms

Gene(s)

CALR

Method

PCR fragment size analysis

Turn around time

14 days

Medicare eligibility

73397 – criteria apply

Price

If not MBS eligible please contact 1800 822 999 for details

Test request form

Standard pathology request form

Sample type

Blood EDTA 6mL or Bone Marrow EDTA 4mL

Collection type

Blood or bone marrow

Special instructions

None